Symposium on gastrooesophageal reflux and its complications. 4. Pharmacology and therapeutics

Management of Helicobacter pylori-related disorders.

European journal of gastroenterology & hepatology·2012

Motility of Helicobacter pylori in a viscous environment.

European journal of gastroenterology & hepatology·1999

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.

Alimentary pharmacology & therapeutics·1998

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.

Gut·1998

Is the only good Helicobacter a dead Helicobacter?

Helicobacter·1997

Management of Helicobacter pylori-related disorders.

European journal of gastroenterology & hepatology·1997

Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts.

Gut·2026

Microbiota-host genetic interactions modulate MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions.

Gut·2026

Regulatory T cells in autoimmune liver diseases.

Gut·2026

Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

Gut·2026

Rewinding the gut clock: from chronodisruption to targeted therapies.

Gut·2026

Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.

Gut·2026

Serial Calcium Monitoring Revealed Primary Hyperparathyroidism in Severe Acute Pancreatitis: A Case Report.

Acute medicine & surgery·2026

Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications.

Cureus·2026

Apixaban After Alteplase for Pulmonary Embolism.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2026

Olive leaf-derived exosome-like vesicles attenuate neurotoxicity in an in vitro rotenone model of Parkinson's disease.

Metabolic brain disease·2026

Reducing the risk of obesity, diabetes, and metabolic disorders in patients treated with antipsychotics - recommendations of the Polish Psychiatric Association Part II: diagnostics and pharmacological treatment.

Psychiatria polska·2026

Tau protein in Parkinson's disease: advances in phosphoproteomics and molecular dynamics simulations.

Frontiers in aging neuroscience·2026

Related Experiment Videos

Symposium on gastrooesophageal reflux and its complications. 4. Pharmacology and therapeutics

Related Concept Videos

Management of Helicobacter pylori-related disorders.

Motility of Helicobacter pylori in a viscous environment.

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.

Is the only good Helicobacter a dead Helicobacter?

Management of Helicobacter pylori-related disorders.

Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts.

Microbiota-host genetic interactions modulate MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions.

Regulatory T cells in autoimmune liver diseases.

Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

Rewinding the gut clock: from chronodisruption to targeted therapies.

Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.

Serial Calcium Monitoring Revealed Primary Hyperparathyroidism in Severe Acute Pancreatitis: A Case Report.

Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications.

Apixaban After Alteplase for Pulmonary Embolism.

Olive leaf-derived exosome-like vesicles attenuate neurotoxicity in an in vitro rotenone model of Parkinson's disease.

Reducing the risk of obesity, diabetes, and metabolic disorders in patients treated with antipsychotics - recommendations of the Polish Psychiatric Association Part II: diagnostics and pharmacological treatment.

Tau protein in Parkinson's disease: advances in phosphoproteomics and molecular dynamics simulations.

Related Experiment Videos

Symposium on gastrooesophageal reflux and its complications. 4. Pharmacology and therapeutics

Related Concept Videos

Related Articles